COPT Defense Properties (NYSE:CDP – Get Free Report) issued its quarterly earnings data on Monday. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.07, RTT News reports. COPT Defense Properties had a net margin of 20.10% and a return on equity of 10.02%. The firm had revenue of $197.39 million during the quarter, compared to the consensus estimate of $189.36 million. During the same quarter in the previous year, the firm posted $0.34 EPS. COPT Defense Properties updated its FY 2026 guidance to 1.390-1.430 EPS and its Q3 2026 guidance to 0.370-0.390 EPS.
COPT Defense Properties Stock Up 0.6%
Shares of CDP opened at $38.27 on Tuesday. The company has a current ratio of 2.85, a quick ratio of 2.85 and a debt-to-equity ratio of 1.63. The firm has a market capitalization of $4.34 billion, a P/E ratio of 27.74 and a beta of 0.76. The firm has a fifty day moving average price of $34.83 and a 200-day moving average price of $32.64. COPT Defense Properties has a 12-month low of $26.91 and a 12-month high of $38.54.
COPT Defense Properties Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Tuesday, June 30th were given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend was Tuesday, June 30th. COPT Defense Properties’s dividend payout ratio is 92.75%.
Analyst Ratings Changes
Insider Activity
In other COPT Defense Properties news, Director Robert L. Denton sold 3,922 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $32.38, for a total transaction of $126,994.36. Following the completion of the sale, the director owned 3,803 shares in the company, valued at $123,141.14. This represents a 50.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.66% of the company’s stock.
Institutional Investors Weigh In On COPT Defense Properties
Large investors have recently made changes to their positions in the stock. Royal Bank of Canada boosted its holdings in COPT Defense Properties by 12.1% in the first quarter. Royal Bank of Canada now owns 104,602 shares of the company’s stock valued at $2,853,000 after purchasing an additional 11,316 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of COPT Defense Properties by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 67,030 shares of the company’s stock worth $1,828,000 after purchasing an additional 2,931 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of COPT Defense Properties by 5.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 834,042 shares of the company’s stock worth $22,744,000 after purchasing an additional 39,683 shares in the last quarter. Jane Street Group LLC raised its position in shares of COPT Defense Properties by 152.4% during the 1st quarter. Jane Street Group LLC now owns 214,122 shares of the company’s stock worth $5,839,000 after purchasing an additional 129,303 shares during the last quarter. Finally, Invesco Ltd. raised its position in shares of COPT Defense Properties by 11.8% during the 2nd quarter. Invesco Ltd. now owns 758,513 shares of the company’s stock worth $20,920,000 after purchasing an additional 80,153 shares during the last quarter.
COPT Defense Properties Company Profile
COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.
The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.
See Also
- Five stocks we like better than COPT Defense Properties
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for COPT Defense Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COPT Defense Properties and related companies with MarketBeat.com's FREE daily email newsletter.
